Dhoot, D S
Pieramici, D J
Nasir, M
Castellarin, A A
Couvillion, S
See, R F
Steinle, N
Bennett, M
Rabena, M
Avery, R L
Article History
Received: 6 August 2014
Accepted: 7 December 2014
First Online: 30 January 2015
Competing interests
: Dr Dhoot is a consultant for Regeneron. Dr Pieramici is a consultant for Genentech, Inc., Alimera, Allergan, Santen, and ThromboGenics. Dr Castellarin is a consultant for Genentech, Inc. and has a personal financial interest with Alcon. Dr Couvillion has received research funding from Genentech, Inc. Dr Steinle is a speaker for Regeneron. Dr Bennett has received research funding from Genentech, Inc. M. Rabena has received honoraria from Genentech, Inc. Dr Avery is a consultant for Alcon, Allergan, Genentech, Inc., Notal Vision, Novartis, Ophthotech, QLT, Regeneron, and Replenish; has received financial support from Allergan and Genentech, Inc.; has received research funding from Allergan, Genentech, Inc., Novartis, and Regeneron; has a personal financial interest with Alexion, I-Tech JV Development, Novartis, Regeneron, and Replenish; and holds a patent with Replenish. Drs Nasir and See declare no potential conflicts of interest.